Loading...
People with diabetes are at increased risk for new heart failure (HF), especially when glucose levels are poorly controlled. Are elevated glucose levels associated with incident HF in a broader group of patients at high risk for cardiovascular disease (CVD)?
To find out, researchers analyzed data from more than 30,000 patients (age ≥55) without known HF who were enrolled in two manufacturer-funded, randomized, controlled trials of the angiotensin-receptor blocker telmisartan (ONTARGET and TRANSCEND). All subjects had histories of symptomatic CVD or of diabetes with end-organ damage. Patients were placed in five categories: low-normal fasting plasma glucose (FPG) level (<5.0 mmol/L); high-normal FPG (5.0 mmol/L to <5.6 mmol/L); impaired FPG (…